Description
Invokana contains canagliflozin, an SGLT2 inhibitor used with diet and exercise to lower blood glucose in type 2 diabetes. It works in the kidneys, reducing how much glucose is reabsorbed so that more is passed out in the urine. The tablet is taken once a day, usually before the first meal of the day, and is swallowed whole.
Because more sugar passes into the urine, genital thrush and urinary infections happen more often; washing and drying the genital area and drinking enough fluid both help. You may pass more urine than usual and feel light-headed on standing, especially in hot weather, during illness, or alongside a diuretic. SGLT2 inhibitors can cause diabetic ketoacidosis even when blood glucose readings look normal, so seek urgent advice for vomiting, stomach pain, deep breathing or a sweet smell on the breath. Check your feet regularly and report any new sore or ulcer.
- SGLT2 inhibitor for type 2 diabetes, used with diet and exercise
- Contains canagliflozin, 100mg and 300mg tablets
- Taken once a day, usually before the first meal
- Genital thrush and urinary infections are more likely
- Risk of ketoacidosis; seek urgent advice for vomiting or stomach pain
- Check your feet and report any new sore or ulcer
